Correlation Between Sino Biopharmaceutica and Rigel Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sino Biopharmaceutica and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sino Biopharmaceutica and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sino Biopharmaceutical Ltd and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Sino Biopharmaceutica and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sino Biopharmaceutica with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sino Biopharmaceutica and Rigel Pharmaceuticals.

Diversification Opportunities for Sino Biopharmaceutica and Rigel Pharmaceuticals

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sino and Rigel is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Sino Biopharmaceutical Ltd and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Sino Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sino Biopharmaceutical Ltd are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Sino Biopharmaceutica i.e., Sino Biopharmaceutica and Rigel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sino Biopharmaceutica and Rigel Pharmaceuticals

Assuming the 90 days horizon Sino Biopharmaceutica is expected to generate 2.89 times less return on investment than Rigel Pharmaceuticals. But when comparing it to its historical volatility, Sino Biopharmaceutical Ltd is 1.87 times less risky than Rigel Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  1,260  in Rigel Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  1,501  from holding Rigel Pharmaceuticals or generate 119.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy83.13%
ValuesDaily Returns

Sino Biopharmaceutical Ltd  vs.  Rigel Pharmaceuticals

 Performance 
       Timeline  
Sino Biopharmaceutical 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sino Biopharmaceutical Ltd are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Sino Biopharmaceutica showed solid returns over the last few months and may actually be approaching a breakup point.
Rigel Pharmaceuticals 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Sino Biopharmaceutica and Rigel Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sino Biopharmaceutica and Rigel Pharmaceuticals

The main advantage of trading using opposite Sino Biopharmaceutica and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sino Biopharmaceutica position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.
The idea behind Sino Biopharmaceutical Ltd and Rigel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account